Bliede Van den Broeck

ORCID: 0000-0002-7235-9990
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Radiation Dose and Imaging
  • Sarcoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Treatment and Research
  • Advanced X-ray and CT Imaging
  • Lung Cancer Research Studies
  • Cardiac tumors and thrombi
  • Advanced MRI Techniques and Applications
  • MRI in cancer diagnosis
  • Esophageal and GI Pathology
  • Migration, Identity, and Health
  • Digital Radiography and Breast Imaging
  • Multiple Myeloma Research and Treatments
  • Bone health and treatments
  • Chemotherapy-related skin toxicity
  • Infective Endocarditis Diagnosis and Management
  • Gallbladder and Bile Duct Disorders
  • Testicular diseases and treatments
  • Sarcoidosis and Beryllium Toxicity Research

Ghent University Hospital
2016-2025

Universitair Ziekenhuis Brussel
2024

AZ Sint-Lucas
2017

Lucas Research
2017

Universitair Ziekenhuis Leuven
2016

<sup>18</sup>F-labeled somatostatin analogs (SSAs) could represent a valid alternative to the current gold standard, <sup>68</sup>Ga-labeled SSAs, for receptor imaging in patients with neuroendocrine tumors (NETs), given their logistic advantages. Recently, <sup>18</sup>F-AlF-NOTA-octreotide (<sup>18</sup>F-AlF-OC) has emerged as promising candidate, but thorough comparison <sup>68</sup>Ga-DOTA-SSA large patient groups is needed. This prospective, multicenter trial aims demonstrate...

10.2967/jnumed.122.264563 article EN Journal of Nuclear Medicine 2022-10-20

Q.Clear is a block sequential regularized expectation maximization (BSREM) penalized-likelihood reconstruction algorithm for PET. It tries to improve image quality by controlling noise amplification during reconstruction. In this study, the properties of BSREM were compared ordered-subset (OSEM) both phantom and patient data acquired on state-of-the-art PET/CT.The NEMA IQ whole-body study GE DMI 3-rings system in list mode different datasets with varying levels generated. Phantom was...

10.1186/s40658-019-0264-9 article EN cc-by EJNMMI Physics 2019-12-01

This study compares inter- and intraobserver agreement between [18F]AlF-NOTA-octreotide ([18F]AlF-OC) [68Ga]Ga-DOTA-somatostatin analogues (SSAs) in PET/CT imaging for neuroendocrine neoplasm (NEN) patients. is a secondary endpoint analysis from our multicenter trial (clin trial.gov identifier: NCT04552847) including 75 NEN patients who received both [68Ga]Ga-DOTATATE (n = 56) or [68Ga]Ga-DOTA-NOC 19) [18F]AlF-OC PET imaging. Five readers assessed lesion detection characterization across...

10.1186/s41824-025-00250-y article EN cc-by-nc-nd Deleted Journal 2025-05-14

Shallow-depth sequencing of cell-free DNA, a cheap and standardized approach to obtain molecular information on tumors non-invasively, is insufficiently explored for lymphoma diagnosis disease follow-up. This study collected 318 samples, including longitudinal liquid paired solid biopsies, from prospectively recruited cohort 38 Hodgkin (HL) 85 aggressive B-cell non- HL patients, represented by 81 diffuse large (DLBCL) cases. Following sequencing, copy number alterations viral read fractions...

10.3324/haematol.2020.268813 article EN cc-by-nc Haematologica 2020-12-10

Patients diagnosed with radioiodine refractory (RAI-R) thyroid carcinoma (TC) have a significantly worse prognosis than patients radiosensitive TC. These malignancies are often dedifferentiated, hindering the effectiveness of iodine-based imaging. Additionally, role metabolic imaging using [

10.1186/s13550-024-01148-9 article EN cc-by-nc-nd EJNMMI Research 2024-09-12

10.1007/s00259-014-2900-x article EN European Journal of Nuclear Medicine and Molecular Imaging 2014-09-18

Abstract Radiation myositis is an infrequent late adverse effect of radiotherapy (RT), more commonly seen after hypofractionated regimens. We present the case a 52-year-old woman with oligorecurrent metastatic melanoma who, several months receiving local RT, developed painful swelling at irradiated site. As integral part routine oncologic follow-up, 18 F-FDG PET/CT allowed accurate visualization affected region and when matched RT treatment plans clearly illustrated their apparent overlap....

10.1097/rlu.0000000000003596 article EN Clinical Nuclear Medicine 2021-03-30

As the spatial resolution of positron emission tomography (PET) scanners improves, understanding radiotracer distributions in tissues at high resolutions is important. Hence, we propose a method for co-registration high-resolution ex vivo specimen PET images, combined with computed (CT) and corresponding histopathology.

10.1186/s40658-024-00681-9 article EN cc-by-nc-nd EJNMMI Physics 2024-10-14

Prostate carcinoma is the most common cancer in men. After local therapy, disease recurs many patients. A choline PET/CT indicated case of biochemical relapse prostate to determine site recurrence (local and/or distant) and help select next line therapy. Choline PET-CT also known show an elevated uptake hyperfunctioning parathyroid adenoma. This report shows difficulty distinguish between both entities if they occur simultaneously oncologic patient.

10.1097/rlu.0000000000001550 article EN Clinical Nuclear Medicine 2017-02-14

OBJECTIVE:To determine the effect of repetitive transcranial magnetic stimulation (rTMS) on brain metabolism and seizure frequency. BACKGROUND:Low-frequency rTMS targeted to epileptic focus may reduce frequency. We hypothesized that changes in metabolism, which have been observed healthy controls after rTMS, could be a biomarker anti-epileptic activity rTMS. METHODS:We performed double-blind, sham controlled, cross-over trial 0.5 Hz over 11 patients with well-characterized neocortical...

10.1212/wnl.86.16_supplement.p5.010 article EN Neurology 2016-04-05

The use of 18F-FDG PET/CT to evaluate patients with multiple myeloma. Detection bone lesions are important diagnose In this study we investigate the role an exam. Fifteen newly diagnosed myeloma were included in retrospective study. A was performed at diagnosis and after induction therapy. response a treatment is examined by semi-quantitative parameters (standardised uptake values) volumetric (metabolic tumor volume total lesion glycolysis). aim these for evaluation risk assessment...

10.47671/tvg.77.21.180 article EN Tijdschrift voor Geneeskunde 2021-10-25
Coming Soon ...